July 28 (Reuters) - Thermo Fisher Scientific Inc (TMO.N), opens new tab on Wednesday raised its full-year revenue outlook, but cut its COVID-19 test sales forecast by $900 million, citing slowing ...

Thermo Fisher Scientific, the world leader in serving science, announced it has received an expansion of its Emergency Use Authorization (EUA) for the TaqPath COVID-19 Combo Kit to include an ...

Thermo Fisher Scientific's TMO business continues to get dampened by lower COVID-19 sales and slower economic activity in China. Also, currency fluctuations continue to dampen top-line growth. The ...

Nov 10 (Reuters) - The University of Oxford has partnered with U.S.-based Thermo Fisher Scientific (TMO.N), opens new tab to ramp up its capacity to deliver COVID-19 testing data and help collect and ...

Wide-moat Thermo Fisher Scientific finished 2021 with strong results as the pandemic continues to demand additional testing requirements and vaccine materials globally. COVID-19 response revenue ...

Thermo Fisher didn’t just come out of the toughest two years for the global economy unscathed, the company managed to deliver its best year ever despite challenges around the economy and spending ...

Thermo Fisher has one of the best recurring revenue models in the world, through which it is exposed to the entire healthcare sector. It forms a duopoly alongside Danaher, and thanks to its leadership ...

Thermo Fisher Scientific is a leading research and development company and provider of laboratory products and services headquartered in Waltham. On August 23, Reuters announced that Novo Nordisk has ...

Thermo Fisher initiates 2024 revenue guidance of $42.1 billion-$43.3 billion versus the consensus of $42.95 billion. Organic revenue was 7% lower, Core organic revenue growth declined 4%, and COVID-19 ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the stocks Jim Cramer put under the microscope. When Cramer was asked about the stock, he commented: “Oh yeah… they really got hurt by COVID. I gotta ...